Pharis Biotec GmbH

"Pharis is a biotechnological-biopharmaceutical group of companies with the aim of isolating and modifying new body-own peptides and proteins as substances, which can be produced in a suitable form to be used as medication. Originating from the applied research of the former Lower Saxony Institute for Peptide Research in Hannover, the group concerns itself with the discovery and development of innovative drugs, particularly for cardiovascular, metabolic and infectious diseases, in order to create optimized medications and added value for investors, employees and partners."

Contact Details: Hannover Germany Tel: Fax: Email: WWW: www.pharis-biotech.de/

Pharis Biotec GmbH Patents:
US Patent No.	Title
7045594	Serine proteinase inhibitors
7033997	Use of natriuretic peptides as antibiotically active substances for the treatment of bacterial infections
6939851	Serine proteinase inhibitors
6849593	Bifidogenic peptides
6831064	Use of urodilatin for treating chronic kidney failure with residual kidney functions
→View more Pharis Biotec GmbH patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 9 times since April 2007, the link to the organisation's website has been followed 2 times

Search for more companies in Hannover

Search for more companies in

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Pharis Biotec GmbH